(Q38865926)

7 September 2017

title

Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence? (English)

1 reference

7 September 2017

0 references

0 references

Karima Chaabna

1

0 references

Henry Wabinga

3

object named as

Henry R Wabinga

1 reference

7 September 2017

Freddie Bray

2

1 reference

7 September 2017

Eric Chokunonga

4

1 reference

7 September 2017

Margaret Borok

5

1 reference

7 September 2017

Philippe Vanhems

6

1 reference

7 September 2017

David Forman

7

1 reference

7 September 2017

Isabelle Soerjomataram

8

1 reference

7 September 2017

language of work or name

English

0 references

publication date

8 March 2013

1 reference

International Journal of Cancer

7 September 2017

published in

1 reference

7 September 2017

volume

133

1 reference

7 September 2017

issue

5

1 reference

7 September 2017

page(s)

1197-1203

1 reference

Kaposi's sarcoma in Uganda: A clinico‐pathological study

7 September 2017

cites work

1 reference

The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic

21 January 2018

1 reference

Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

21 January 2018

1 reference

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007

21 January 2018

1 reference

Uganda's HIV prevention success: the role of sexual behavior change and the national response

21 January 2018

1 reference

A surprising prevention success: why did the HIV epidemic decline in Zimbabwe?

21 January 2018

1 reference

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

21 January 2018

1 reference

21 January 2018

1 reference

Estimating average annual per cent change in trend analysis

21 January 2018

1 reference

21 January 2018

1 reference

Slim disease: a new disease in Uganda and its association with HTLV-III infection.

21 January 2018

1 reference

Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives

21 January 2018

1 reference

A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa

21 January 2018

1 reference

Population-level HIV declines and behavioral risk avoidance in Uganda

21 January 2018

1 reference

Partner reduction is crucial for balanced "ABC" approach to HIV prevention

21 January 2018

1 reference

Sex and Geographic Patterns of Human Herpesvirus 8 Infection in a Nationally Representative Population‐Based Sample in Uganda

21 January 2018

1 reference

Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt"

21 January 2018

1 reference

Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology

21 January 2018

1 reference

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

Association of Kaposi's sarcoma with second primary malignancies possible etiopathogenic implications

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28125

1 reference

7 September 2017

1 reference